PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-07-23

Date Title Company
23-Jul-2025 Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants ACCESS Newswire
23-Jul-2025 Abivax Announces Launch of Public Offering ABIVAX
23-Jul-2025 AlzeCure's Rights Issue Oversubscribed According to Preliminary Results ACCESS Newswire
23-Jul-2025 ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025 ACCESS Newswire
23-Jul-2025 Champions Oncology Reports Record Annual Revenue of $57 Million ACCESS Newswire
23-Jul-2025 Psilocybin Alliance Announces Incorporation and Industry Milestones in Effort to Protect Oregon's Legal Psilocybin Program ACCESS Newswire
23-Jul-2025 Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies Mainz BioMed N.V.
23-Jul-2025 European Commission approves DARZALEX® (daratumumab) as the first licensed treatment for patients with high-risk smouldering multiple myeloma J&J
23-Jul-2025 Black Book Survey Highlights Growing Divide Over AI Regulation in U.S. Healthcare ACCESS Newswire
23-Jul-2025 European Commission approves IMBRUVICA® (ibrutinib) as the first targeted therapy for patients with previously untreated mantle cell lymphoma who would be eligible for autologous stem cell transplant J&J
23-Jul-2025 Paralign Health Launches to Transform Preventative Care for Medically Underserved Americans ACCESS Newswire
23-Jul-2025 The importance of effective hospital waste management Anenta
23-Jul-2025 Viz.ai Named #1 in 2025 Black Book Survey of AI-Powered Acute Care & Clinical Decision Support Vendors ACCESS Newswire
23-Jul-2025 IGC Pharma to Present Advanced AI Platforms for Alzheimer's Disease at the AAIC 2025 ACCESS Newswire
23-Jul-2025 Veterans Cannabis Care Launches Nationwide Network to Provide FREE Medical Cannabis Recommendations to Veterans ACCESS Newswire
23-Jul-2025 NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value ACCESS Newswire
23-Jul-2025 Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform ACCESS Newswire
23-Jul-2025 Abbott Introduces First-of-Its-Kind Hypoallergenic Infant Formula on Prescription in the UK [1] Abbott
23-Jul-2025 CaringAI Launches Voice-Based Dementia Care Platform, Appoints Dr. Stephanie Ruth Young as Clinical Research Advisor ACCESS Newswire
23-Jul-2025 ESSE Care Welcomes Dr. Leigh Rosen, MD: Expanding Access to Reproductive Health in Manhattan and Greenwich ACCESS Newswire